Positron Emission Tomography/Computed Tomography with Gallium-68–labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model

Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts

(2018) Kwanghee Kim et al.   CLINICAL CANCER RESEARCH

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid

(2018) Birthe Heitkötter et al.   Oncotarget

PSMA Theranostics: Current Status and Future Directions

(2018) Kambiz Rahbar et al.   Molecular Imaging

Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy

(2017) Anna Katharina Seitz et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Trends in the Incidence of Fatal Prostate Cancer in the United States by Race

(2017) Scott P. Kelly et al.   EUROPEAN UROLOGY

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

(2017) Abdel-Rahmène Azzouzi et al.   LANCET ONCOLOGY

Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight

(2017) Heinz H. Coenen et al.   NUCLEAR MEDICINE AND BIOLOGY

QuPath: Open source software for digital pathology image analysis

(2017) Peter Bankhead et al.   Scientific Reports

Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

(2016) Marlon Perera et al.   EUROPEAN UROLOGY

Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy

(2016) Simon Y. Kimm et al.   RADIOLOGY

68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

(2016) Isabel Rauscher et al.   CANCER IMAGING

Magnetic Resonance Imaging of the Prostate, Including Pre- and Postinterventions

(2016) Aytekin Oto et al.   SEMINARS IN INTERVENTIONAL RADIOLOGY

The Role of Pathology Correlation Approach in Prostate Cancer Index Lesion Detection and Quantitative Analysis with Multiparametric MRI

(2015) Andriy Fedorov et al.   ACADEMIC RADIOLOGY

68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

(2015) Francesco Ceci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

(2015) A. R. Azzouzi et al.   WORLD JOURNAL OF UROLOGY

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score

(2015) Kimberly A. Herget et al.   Cancer Medicine

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel

(2013) Berrend G. Muller et al.   BJU INTERNATIONAL

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

(2013) Massimo Valerio et al.   EUROPEAN UROLOGY

The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration

(2012) Jichao Qin et al.   Cell Stem Cell